BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8699628)

  • 1. Effect of serotonin (5-HT)3-receptor antagonists YM060, YM114 (KAE-393), ondansetron and granisetron on 5-HT4 receptors and gastric emptying in rodents.
    Miyata K; Yamano M; Kamato T; Akuzawa S
    Jpn J Pharmacol; 1995 Nov; 69(3):205-14. PubMed ID: 8699628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of the affinities of the 5-HT3 receptor antagonists, YM060, YM114 (KAE-393), granisetron and ondansetron in rat vagus nerve and cerebral cortex.
    Ito H; Akuzawa S; Tsutsumi R; Kiso T; Kamato T; Nishida A; Yamano M; Miyata K
    Neuropharmacology; 1995 Jun; 34(6):631-7. PubMed ID: 7566499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of inhibitory effects of serotonin (5-HT)3-receptor antagonists, YM060 and YM114 (KAE-393), on the von Bezold-Jarisch reflex induced by 2-Methyl-5-HT, veratridine and electrical stimulation of vagus nerves in anesthetized rats.
    Yamano M; Ito H; Kamato T; Miyata K
    Jpn J Pharmacol; 1995 Dec; 69(4):351-6. PubMed ID: 8786638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin (5-HT)3-receptor antagonism of 4,5,6,7-tetrahydrobenzimidazole derivatives against 5-HT-induced bradycardia in anesthetized rats.
    Yamano M; Kamato T; Nishida A; Ito H; Yuki H; Tsutsumi R; Honda K; Miyata K
    Jpn J Pharmacol; 1994 Jul; 65(3):241-8. PubMed ID: 7799524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of gastroprokinetic agents on gastroparesis in streptozotocin-induced diabetic rats.
    Yamano M; Kamato T; Nagakura Y; Miyata K
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):145-50. PubMed ID: 9228202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ramosetron on short-circuit current response in rat colonic mucosa.
    Kiso T; Ito H; Miyata K
    Eur J Pharmacol; 1997 Feb; 320(2-3):187-92. PubMed ID: 9059853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of trimebutine and YM114 (KAE-393), a novel 5-HT3 receptor antagonist, on stress-induced defecation.
    Miyata K; Ito H; Yamano M; Hidaka K; Kamato T; Nishida A; Yuki H
    Eur J Pharmacol; 1993 Dec; 250(2):303-10. PubMed ID: 8112388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Participation of a cholinergic mechanism in 5-hydroxytryptamine (5-HT)3 and 5-HT4 receptor-mediated stimulation of gastric emptying in rats.
    Yamano M; Kamato T; Miyata K
    Arzneimittelforschung; 1997 Nov; 47(11):1242-6. PubMed ID: 9428982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic profile of (R)-5-[(1-methyl-3-indolyl)carbonyl]-4,5,6,7-tetrahydro-1H- benzimidazole hydrochloride (YM060), a potent and selective 5-hydroxytryptamine3 receptor antagonist, and its enantiomer in the isolated tissue.
    Miyata K; Kamato T; Nishida A; Ito H; Katsuyama Y; Iwai A; Yuki H; Yamano M; Tsutsumi R; Ohta M
    J Pharmacol Exp Ther; 1991 Oct; 259(1):15-21. PubMed ID: 1656016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect of YM060 on 5-HT3 receptor-mediated depolarization in colonic myenteric neurons of the guinea pig.
    Ito H; Tamura K
    Eur J Pharmacol; 1995 Sep; 283(1-3):107-12. PubMed ID: 7498299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological properties of KF18259, a novel 5-HT3-receptor antagonist, in rats: inhibition of the distal colonic function.
    Kishibayashi N; Ichikawa S; Yokoyama T; Ishii A; Karasawa A
    Jpn J Pharmacol; 1993 Dec; 63(4):495-502. PubMed ID: 8121082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of YM060, a potent and selective 5-hydroxytryptamine3 receptor antagonist, in rabbit nodose ganglion and N1E-115 neuroblastoma cells.
    Ito H; Hidaka K; Miyata K; Kamato T; Nishida A; Honda K
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1127-32. PubMed ID: 1469624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin (5-HT)3 receptor blocking activities of YM060, a novel 4,5,6,7-tetrahydrobenzimidazole derivative, and its enantiomer in anesthetized rats.
    Miyata K; Kamato T; Yamano M; Nishida A; Ito H; Katsuyama Y; Yuki H; Tsutsumi R; Ohta M; Takeda M
    J Pharmacol Exp Ther; 1991 Nov; 259(2):815-9. PubMed ID: 1941629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Species difference in the 5-hydroxytryptamine3 receptor associated with the von Bezold-Jarisch reflex.
    Yamano M; Ito H; Kamato T; Miyata K
    Arch Int Pharmacodyn Ther; 1995; 330(2):177-89. PubMed ID: 8861711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of 5-HT3 receptor-mediated contraction in guinea-pig distal colon.
    Yamano M; Miyata K
    Eur J Pharmacol; 1996 Dec; 317(2-3):353-9. PubMed ID: 8997621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel 5-hydroxytryptamine (5-HT3) receptor antagonists. III. Pharmacological evaluations and molecular modeling studies of optically active 4,5,6,7-tetrahydro-1H-benzimidazole derivatives.
    Ohta M; Suzuki T; Furuya T; Kurihara H; Tokunaga T; Miyata K; Yanagisawa I
    Chem Pharm Bull (Tokyo); 1996 Sep; 44(9):1707-16. PubMed ID: 8855365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on serotonin (5-HT)3-receptor antagonist effects of enantiomers of 4,5,6,7-tetrahydro-1H-benzimidazole derivatives.
    Kamato T; Ito H; Suzuki T; Miyata K; Honda K
    Jpn J Pharmacol; 1995 Mar; 67(3):185-94. PubMed ID: 7630036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological analyses of endo-6-methoxy-8-methyl-8-azabicyclo[3.2.1]oct-3-yl-2,3-dihydro-2-oxo-1 H- benzimidazole-1-carboxylate hydrochloride (DAU 6285) at the 5-hydroxytryptamine4 receptor in the tunica muscularis mucosae of rat esophagus and ileum of guinea pig: role of endogenous 5-hydroxytryptamine.
    Waikar MV; Hegde SS; Ford AP; Clarke DE
    J Pharmacol Exp Ther; 1993 Feb; 264(2):654-61. PubMed ID: 8437113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of 2-piperazinylbenzothiazole and 2-piperazinylbenzoxazole derivatives with 5-HT3 antagonist and 5-HT4 agonist properties.
    Monge A; Peña MC; Palop JA; Calderó JM; Roca J; García E; Romero G; del Río J; Lasheras B
    J Med Chem; 1994 Apr; 37(9):1320-5. PubMed ID: 8176710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel 5-hydroxytryptamine (5-HT3) receptor antagonists. IV. Synthesis and pharmacological evaluation of the oxidation products of (-)-(R)-5-[(1-methyl-1H-indol-3-yl)carbonyl] -4,5,6,7-tetrahydro-1H-benzimidazole hydrochloride (YM060: ramosetron).
    Ohta M; Suzuki T; Nagashima S; Tokunaga T; Miyata K; Mase T
    Chem Pharm Bull (Tokyo); 1996 Sep; 44(9):1717-22. PubMed ID: 8855366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.